Label

How We Work

Grant

Back

Print

Altor BioScience Corporation


October 2008
to engineer single chain T cell receptors to deliver immunotherapies to HIV-infected cells to recognize known viral variants linked to the emergence of drug-resistant HIV mutations
$100,000
18
Discovery and Translational Sciences
Global Health
Miramar, Florida

Visit Our Blog